Regulation of caspase activation in apoptosis: Implications for transformation and drug resistance

Cytotechnology

Volumn 27, Issue 1-3, 1998, Pages 309-320

  Slee, Elizabeth A ^a   Martin, Seamus J ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Apoptosis; Caspases; Cell death; Proteases; Proteolysis

Indexed keywords

APOPTOSIS; CASPASE; CYSTEINE PROTEINASE; CYTOTOXICITY; DRUG RESISTANCE; ENZYME ACTIVATION; PROTEIN DEGRADATION;

EID: 0032414886     PISSN: 09209069     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-94-017-2374-9_21     Document Type: Article

References (82)

1. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW and Yuan J (1996) Human ICE/CED-3 protease nomenclature. Cell 87: 171-172.
2. Amarante-Mendes GP and Green DR (1997) Abi tyrosine kinase and the control of apoptosis. In Martin SJ (ed) Apoptosis and Cancer, (pp. 98-115). Karger Landes Systems, Basel.
3. Ameisen JC (1996) The origin of programmed cell death. Science 272: 1278-1279.
4. Bellamy COC, Malcomson R and Wyllie AH (1997) The roles of p53 in apoptosis and cancer. In Martin SJ (ed) Apoptosis and Cancer, (pp. 116-140). Karger Landes Systems, Basel.
5. Bissonnette RP, Echeverri F, Mahboubi A and Green DR (1992) Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359: 552-554
6. Boldin MP, Goncharov TM, Goltsev YV, Wallach D (1996) Involvement of MACH, a novel MORTl/FADD-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death. Cell 85: 803-815.
7. Bump NJ, Hackett M, Hugunin M, Seshagiri S, Brady K, Chen P, Ferenz C, Franklin S, Ghayur T, Li P, Licari P, Mankovich J, Shi L, Greenberg AH, Miller LK and Wong WW (1995) Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 269: 1885-1888.
8. Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, Ueno K and Hardwick JM (1997) Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278: 1966-1968.
9. Chinnaiyan AM, O'Rourke K, Lane BR and Dixit VM (1997) Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science 275: 1122-1126.
10. Clem RJ, Fechheimer M and Miller LK (1991) Prevention of apoptosis by a baculovirus gene during infection of insect cells. Science 254: 1388-1390.
11. Darmon AJ, Nicholson DW and Bleackley RC (1995) Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 377: 446-448.
12. Devereaux QL, Takahashi R, Salvesen GS and Reed JC (1997) X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388: 300-304.
13. Duan H, Chinnaiyan AM, Hudson PL, Wing JP, He WW and Dixit VM (1996) ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas- and tumor necrosis factor-induced apoptosis. J Biol Chem271: 1621-1625.
14. Ellis RE, Yuan J and Horvitz HR (1991) Mechanisms and function of cell death. Annu Rev Cell Biol 7: 663-698.
15. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A and Nagata S (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391: 43-50.
16. Fanidi A, Harrington EA and Evan GI (1992) Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359: 554-556.
17. Fujiwara T, Cai DW, Georges RN, Mukhopadhyay T, Grimm EA and Roth JA (1994) Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model. J Natl Cancer Inst 86: 1458-1462.
18. Fujiwara T, Grimm EA, Mukhopadhyay T, Cai DW, Owen-Schaub LB and Roth JA (1993) A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res 53: 4129-4133.
19. Gagliardini V, Fernandez P-A, Lee RKK, Drexler HCA, Rotello RJ, Fishman MC and Yuan J (1994) Prevention of vertebrate neuronal death by the CrmA gene. Science 263: 826-828.
20. Harvey ML, Butt AJ and Kumar S (1997) Functional activation of Nedd2/ICH-l (caspase-2) is an early process in apoptosis. J Biol Chem272: 13134-13139.
21. Herr I, Wilhelm D, Bohler T, Angel P and Debatin KM (1997) Activation of CD95 (APO-I/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J 16: 6200-6208.
22. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE and Tschopp J (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388: 190-195.
23. Jacobson MD, Weil M and Raff MC (1997) Programmed cell death in animal development. Cell 88: 347-354.
24. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH and Peter ME (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14: 5579-5588.
25. Kluck RM, Bossy-Wetzel E, Green DR and Newmeyer DD (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136.
26. Kothakota S, Azuma T, Reinhard C, Klippe! A, Tang J, Chu K, McGarry TJ, Kirschner MW, Koths K, Kwiatkowski DJ and Williams LT (1997) Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 278: 294-298.
27. Lennon, SV, Martin SJ and Cotter TG (1991) Dose-dependent induction of apoptosis in human tumor cell lines by widely diverging stimuli. Cell Prolif 24: 203-214.
28. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489
29. Liu X, Zou H, Slaughter C and Wang X (1997) DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89: 175-184.
30. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE and Jacks T (1994) p53 status and the efficacy of cancer therapy in vivo. Science 266: 807-810.
31. Lowe SW, Ruley HE, Jacks T and Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967.
32. MacFarlane M, Cain K, Sun XM, Alnemri ES and Cohen GM (1997) Processing/activation of at least four interleukin-1 beta converting enzyme-like proteases occurs during the execution phase of apoptosis in human monocytic tumor cells. J Cell Biol 137: 469-479.
33. Martin SJ and Green DR (1995a) Apoptosis and Cancer: the failure of controls on cell death and cell survival. Crit Rev Oncol Hematol 18: 137-153.
34. Martin SJ and Green DR (1995b) Protease activation during apoptosis: death by a thousand cuts? Cell 82: 349-352.
35. Martin SJ (1997) Apoptosis and cancer: an overview. In Martin SJ (ed) Apoptosis and Cancer, (pp. 1-8). Karger Landes Systems, Basel.
36. Martin SJ, Amarante-Mendes GP, Shi L, Chuang T-H, Casiano CA, O'Brien GA, Fitzgerald P, Tan EM, Bokoch GM, Greenberg AH and Green DR (1996) The cytotoxic cell protease granzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of the ICE/CED-3 family protease, CPP32, via a novel two-step mechanism. EMBO J 15: 2407-2416.
37. Martin, SJ and Cotter TG (1990) Disruption of microtubules induces an engogenous suicide pathway in human leukaemia HL-60 cells. Cell Tissue Kinet 23: 545-559.
38. McCarthy NJ, Whyte MK, Gilbert CS and Evan GI (1997) Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J Cell Biol 136: 215-227.
39. McDonnell TJ and Korsmeyer SJ (1991) Progression from lymphoid hyperplasia to high grade malignant lymphoma in mice transgenic for the t(14;18). Nature 349: 254-256.
40. McDonnell TJ, Deane N and Platt FM et al. (1989) Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57: 79-89.
41. McDonnell TJ, Troncoso P and Brisbay SM etal. (1992) Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independant prostate cancer. Cancer Res 52: 6940-6944.
42. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH and Peter ME (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 16:2794-2804.
43. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME and Dixit VM (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signalling complex. Cell 85: 817-827.
44. Miyashita T and Reed JC (1993) Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81: 151-157.
45. Nagata S and Golstein P (1995) The Fas death factor. Science 267: 1449-1455.
46. Nagata S (1997) Apoptosis by death factor. Cell 88: 355-365.
47. Nicholson DW and Thornberry NA (1997) Caspases: killer proteases. Trends Biochem Sci 8: 299-306.
48. Nicholson DW (1996) ICE/CED-3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nature Biotechnol 14: 297-301.
49. Raff MC (1992) Social controls on cell survival and cell death. Nature 356: 397-400.
50. Raff MC (1996) Size control: the regulation of cell numbers in animal development. Cell 86: 173-175.
51. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y and Jacobson MD (1993) programmed cell death and the control of cell survival: lessons from the nervous system. Science 262: 695-700.
52. Reed JC (1997a) Bcl-2 family proteins: role in dysregulation of apoptosis and chemoresistance in cancer. In Martin SJ (ed) Apoptosis and Cancer, (pp. 64-97). Karger Landes Systems, Basel.
53. Reed JC (1997b) Double identity for proteins of the Bcl-2 family. Nature 387: 773-776.
54. Rotonda J, Nicholson DW, Fazil KM, Gallant M, Gareau Y, Labelle M, Peterson EP, Rasper DM, Ruel R, Vaillancourt JP, Thornberry NA and Becker JW (1996) The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nat Struct Biol 3: 619-625.
55. Salvesen GS and Dixit VM (1997) Caspases: intracellular signaling by proteolysis. Cell 91: 443-446.
56. Savill JS, Fadok V, Henson P and Haslett C (1993) Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14: 131-136.
57. Schlegel J, Peters I, Orrenius S, Miller DK, Thornberry NA, Yamin TT and Nicholson DW (1996) CPP32/apopain is a key interleukin-1 b converting enzyme-like protease involved in Fasmediated apoptosis. J Biol Chem 271: 1841-1844.
58. Sheard MA, Vojtesek B, Janakova L, Kovarik J and Zaloudik J (1997) Upregulation of Fas (CD95) in human p53 wild-type cancer cells treated with ionizing radiation. Int J Cancer 73: 757-762.
59. Slee EA, Harte MH and Martin SJ (1998) A duel to the death: activated caspases meet their substrates. Sepsis in press.
60. Slee EA, Zhu H, Chow SC, MacFarlane M, Nicholson DW and Cohen GM (1996) Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J 315: 21-24.
61. Steller H (1995) Mechanisms and genes of cellular suicide. Science 267: 1445-1449.
62. Strasser A, Harris AW, Bath ML and Cory S (1990) Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bd-2. Nature 348: 331-333.
63. Suda T, Takahashi T, Golstein P and Nagata S (1993) Molecular cloning and expression of the Fas ligand: a novel member of the Tumor Necrosis Factor family. Cell 75: 1169-1178.
64. Tewari M and Dixit VM (1995) Fas- and tumor necrosis factorinduced apoptosis is inhibited by the poxvirus CrmA gene product. J Biol Chem 270: 3255-3260.
65. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462.
66. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, Krammer PH, Peter ME and Tschopp J (1997) Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386: 517-521.
67. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, Chapman KT and Nicholson DW (1997) A combinatorial approach defines specificities of members of the caspase family and granzyme B. J Biol Chem 272: 17907-17911.
68. Toft NJ and Arends MJ (1997) Apoptosis and necrosis in tumors. In Martin SJ (ed) Apoptosis and Cancer, (pp. 25-44). Karger Landes Systems, Basel.
69. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, Debatin KM and Krammer PH (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301-305.
70. Tsujimoto Y, Jaffe E, Cossman J and Croce CM (1985) Involvement of the bcl-2 gene in human follicular lymphoma. Science 228: 1440-1443.
71. Villa P, Kaufmann SH and Earnshaw WC (1997) Caspases and caspase inhibitors. Trends Biochem Sci 22: 388-393.
72. Wu D, Wallen HD and Nunez G (1997) Interaction and regulation of subcellular localization of CED-4 by CED-9. Science 275: 1126-1129
73. Wyllie AH, Kerr JFR and Currie AR (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68: 251-306.
74. Wyllie AH, Rose KA, Morris RG, Steel CM, Foster E and Spandidos DA (1987) Rodent fibroblast tumors expressing myc and ras genes. Growth, metastasis, and endogenous oncogene expression. Br J Cancer 56: 251-259.
75. Xiang J, Chao DT and Korsmeyer SJ (1996) BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc Natl Acad Sci USA 93: 14559-14563.
76. Xue D and Horvitz HR (1995) Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein. Nature 377: 248-251.
77. Xue D and Horvitz HR (1997) Caenorhabditis elegans CED-9 protein is a bifunctional cell-death inhibitor. Nature 390: 305-308.
78. Yang J, Liu X, Bhalla K, Kirn CN, Ibrado AM, Cai J, Peng TI, Jones DP and Wang X (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132.
79. Yonehara S, Ishii A and Yonehara M (1989) A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen codownregulated with the receptor of tumor necrosis factor. J Exp Med 169: 1747-1756.
80. Yuan J, Shaham S, Ledoux S, Ellis HM and Horvitz HR (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1b-converting enzyme. Cell 75: 641-652.
81. Zhou Q, Snipas S, Orth K, Muzio M, Dixit VM and Salvesen GS (1997) Target protease specificity of the viral serpin CrmA. Analysis of five caspases. J Biol Chem 272: 7797-7800.
82. Zou H, Henzel WJ, Liu X, Lutschg A and Wang X (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90: 405-413.